ALX Oncology Holdings Inc. (ALXO)
NGS · Common · CUSIP 00166B105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ALXO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00166B105
Market Cap
Small Cap
IPO
7/17/2020 · $19.00/share
Business: ALX Oncology Holdings Inc. is the holding company for ALX Oncology, is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives

Company Contact

CEO
Jason Lettmann
CFO
Harish Shantharam
Headquarters
323 Allerton Avenue, South San Francisco, CA 94080
Phone
650-466-7125
Investor Relations
Peter García · 650-466-7125 · peter@alxoncology.com
General Email
alx@argotpartners.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »